ArticleCancer pathogenesis and therapy2025
Developing and validating a bi-polar gated respiratory motion management strategy for improved lung stereotactic body radiotherapy treatment.
Article in Cancer pathogenesis and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in radiotherapy-based multimodal treatment for non-small-cell lung cancer.Cancer pathogenesis and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Stereotactic body radiotherapy (SBRT) is an effective treatment for early-stage non-small cell lung cancer. However, patient breathing can affect treatment accuracy. Therefore, this study aimed to develop a bi-polar (BP) gated motion management strategy for SBRT and evaluate its feasibility geometrically and dosimetrically. Methods: The BP strategy involved instructing patients to hold their breath briefly at the end of both inhalation (EI) and exhalation (EE), with radiation delivered only during these breath-holding periods. Eight volunteers were included to evaluate breathing stability, repeatability, and patient comfort. Additionally, 15 patients were retrospectively studied to evaluate the geometric and dosimetric efficiency of BP in intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) modes. BP plans were compared with four common breathing strategies: free breathing (FB), gating at the end of inhalation (GI), gating at the end of exhalation (GE), and real-time tracking (RT). Results: Volunteers could comfortably hold their breath for >3 minutes, demonstrating good stability and repeatability. Geometrically, the ratio of BP's internal target volume (ITV) to GI's ITV was the smallest at 0.65, compared to 1.89 for FB, 1.05 for GE, and 0.68 for RT. In the dosimetric evaluation of IMRT plans, the lung V Conclusions: The BP strategy is a feasible option for lung SBRT, offering reduced treatment volumes and normal tissue toxicity, with a high duty cycle and less technical complexity than other RT-based methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.